

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.42769331 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.42769331 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.07488679 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.07488679 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.70519877 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.24856261 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.06077900 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.06077900 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.06077900 |
| 10 | complement activation, alternative pathway (GO:0006957) | 6.05601074 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.94304212 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.89871863 |
| 13 | urea metabolic process (GO:0019627) | 5.74792706 |
| 14 | urea cycle (GO:0000050) | 5.74792706 |
| 15 | regulation of protein activation cascade (GO:2000257) | 5.73049414 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.72237494 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68674958 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.63720143 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.63344098 |
| 20 | protein carboxylation (GO:0018214) | 5.57151178 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.57151178 |
| 22 | negative regulation of protein activation cascade (GO:2000258) | 5.53504047 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.46626370 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.44715014 |
| 25 | regulation of complement activation (GO:0030449) | 5.40592383 |
| 26 | intestinal cholesterol absorption (GO:0030299) | 5.35451095 |
| 27 | regulation of plasminogen activation (GO:0010755) | 5.29177950 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.26606568 |
| 29 | regulation of apoptotic cell clearance (GO:2000425) | 5.21979702 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.20210751 |
| 31 | cysteine metabolic process (GO:0006534) | 5.20119015 |
| 32 | bile acid metabolic process (GO:0008206) | 5.05620710 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.98173544 |
| 34 | regulation of humoral immune response (GO:0002920) | 4.97501069 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92973605 |
| 36 | epoxygenase P450 pathway (GO:0019373) | 4.90616255 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.84511586 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.83261708 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.76762746 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.76732064 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.74193432 |
| 42 | exogenous drug catabolic process (GO:0042738) | 4.73291414 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.72447960 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.72447960 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.72447960 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.72301652 |
| 47 | negative regulation of complement activation (GO:0045916) | 4.70871529 |
| 48 | positive regulation of hemostasis (GO:1900048) | 4.63313354 |
| 49 | positive regulation of blood coagulation (GO:0030194) | 4.63313354 |
| 50 | protein-lipid complex subunit organization (GO:0071825) | 4.62577018 |
| 51 | phospholipid efflux (GO:0033700) | 4.57664890 |
| 52 | negative regulation of blood coagulation (GO:0030195) | 4.54042663 |
| 53 | negative regulation of hemostasis (GO:1900047) | 4.54042663 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.53892753 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.53532741 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.52674181 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.52674181 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.50145496 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.50145496 |
| 60 | lysine catabolic process (GO:0006554) | 4.47173601 |
| 61 | lysine metabolic process (GO:0006553) | 4.47173601 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.44334072 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.42889254 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 4.34894832 |
| 65 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.33500211 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.28173529 |
| 67 | glycine metabolic process (GO:0006544) | 4.27862472 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.26583260 |
| 69 | positive regulation of coagulation (GO:0050820) | 4.25832877 |
| 70 | cholesterol efflux (GO:0033344) | 4.25176031 |
| 71 | cellular glucuronidation (GO:0052695) | 4.23854345 |
| 72 | coenzyme catabolic process (GO:0009109) | 4.23149618 |
| 73 | omega-hydroxylase P450 pathway (GO:0097267) | 4.18961252 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 4.16330744 |
| 75 | amine catabolic process (GO:0009310) | 4.16314114 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 4.16314114 |
| 77 | glutamate metabolic process (GO:0006536) | 4.14396209 |
| 78 | complement activation (GO:0006956) | 4.13657195 |
| 79 | negative regulation of coagulation (GO:0050819) | 4.12813408 |
| 80 | fibrinolysis (GO:0042730) | 4.07760000 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07523522 |
| 82 | ethanol oxidation (GO:0006069) | 4.07140066 |
| 83 | complement activation, classical pathway (GO:0006958) | 4.04608929 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 4.03445316 |
| 85 | serine family amino acid metabolic process (GO:0009069) | 4.02249274 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 4.01857248 |
| 87 | protein activation cascade (GO:0072376) | 3.99689547 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 3.99536386 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98061078 |
| 90 | negative regulation of wound healing (GO:0061045) | 3.95982493 |
| 91 | opsonization (GO:0008228) | 3.91113940 |
| 92 | arginine metabolic process (GO:0006525) | 3.90449649 |
| 93 | positive regulation of extracellular matrix organization (GO:1903055) | 3.88521180 |
| 94 | negative regulation of humoral immune response (GO:0002921) | 3.87409408 |
| 95 | aldehyde catabolic process (GO:0046185) | 3.86538951 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83853350 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.83278688 |
| 98 | serine family amino acid biosynthetic process (GO:0009070) | 3.82688651 |
| 99 | drug catabolic process (GO:0042737) | 3.77594972 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.76666919 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.73838691 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.73838691 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.72851792 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.71669225 |
| 105 | cofactor catabolic process (GO:0051187) | 3.68999090 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68531095 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68531095 |
| 108 | ketone body metabolic process (GO:1902224) | 3.68066510 |
| 109 | lipoprotein metabolic process (GO:0042157) | 3.66794715 |
| 110 | sterol homeostasis (GO:0055092) | 3.66680277 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66617563 |
| 112 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.65962059 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.65023824 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.64229938 |
| 115 | organic acid catabolic process (GO:0016054) | 3.64229938 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.63448399 |
| 117 | negative regulation of lipase activity (GO:0060192) | 3.63439485 |
| 118 | cytolysis (GO:0019835) | 3.63267006 |
| 119 | plasma lipoprotein particle organization (GO:0071827) | 3.62756179 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.57974555 |
| 121 | ethanol metabolic process (GO:0006067) | 3.57196483 |
| 122 | acute-phase response (GO:0006953) | 3.54559787 |
| 123 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.52986862 |
| 124 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.52986862 |
| 125 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.52494784 |
| 126 | acute inflammatory response (GO:0002526) | 3.48551883 |
| 127 | intestinal absorption (GO:0050892) | 3.47895415 |
| 128 | sterol transport (GO:0015918) | 3.41492544 |
| 129 | cholesterol transport (GO:0030301) | 3.41492544 |
| 130 | regulation of acute inflammatory response (GO:0002673) | 3.36275574 |
| 131 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.33924915 |
| 132 | drug metabolic process (GO:0017144) | 3.27614949 |
| 133 | positive regulation of steroid metabolic process (GO:0045940) | 3.26510711 |
| 134 | diacylglycerol metabolic process (GO:0046339) | 3.25162411 |
| 135 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.18429587 |
| 136 | response to mercury ion (GO:0046689) | 3.15275345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.28112482 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.06355085 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.89760296 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49142950 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.20388944 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.92486654 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.57758413 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.08360789 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.86005083 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04412472 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7696221 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.91716914 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82868038 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81731683 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78632209 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66809378 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64434779 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54837769 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53587538 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51518305 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49954184 |
| 22 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.49278085 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42724954 |
| 24 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39168758 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25694651 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20073218 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19499921 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15263589 |
| 29 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13305031 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.08425358 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05399402 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.04137898 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02293714 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99105023 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99017752 |
| 36 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93567732 |
| 37 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93157967 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92338561 |
| 39 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90773409 |
| 40 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90217440 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.87477454 |
| 42 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86939804 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86922753 |
| 44 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85433306 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83003016 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.82957992 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.82609649 |
| 48 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82565932 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82145489 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.80541918 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79910225 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79233336 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78064258 |
| 54 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.77121325 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77115224 |
| 56 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76766084 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75375039 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75375039 |
| 59 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.75333626 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.75304586 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74735311 |
| 62 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.73632104 |
| 63 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.73603447 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.73453791 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.72868727 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72635608 |
| 67 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.71740108 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.71323053 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70749974 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70518154 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70371646 |
| 72 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70027656 |
| 73 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68797276 |
| 74 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68134432 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 0.67223332 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.67130118 |
| 77 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66715470 |
| 78 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66404420 |
| 79 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65968297 |
| 80 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.64850694 |
| 81 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.64351260 |
| 82 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.63732597 |
| 83 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.63657248 |
| 84 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63565475 |
| 85 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62799522 |
| 86 | TP53_16413492_ChIP-PET_HCT116_Human | 0.62765304 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.61878624 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.61120811 |
| 89 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.60274913 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.59559060 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.59353552 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.59159045 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57142300 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.56445524 |
| 95 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56290111 |
| 96 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55291233 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.54927336 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54740069 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54421816 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.54301810 |
| 101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53158682 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.52788724 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52769136 |
| 104 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.52710895 |
| 105 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.52450123 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51153283 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.50462968 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.50368077 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50184070 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48983715 |
| 111 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.48826967 |
| 112 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48724142 |
| 113 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48326082 |
| 114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48257889 |
| 115 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47959024 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.47379406 |
| 117 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47349334 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.47278661 |
| 119 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46888674 |
| 120 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.45053810 |
| 121 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43363693 |
| 122 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43167498 |
| 123 | CBP_21632823_ChIP-Seq_H3396_Human | 0.42618844 |
| 124 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.42227251 |
| 125 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.42219196 |
| 126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42093454 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.41929321 |
| 128 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.41783216 |
| 129 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41525938 |
| 130 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.40941378 |
| 131 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39996911 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39580306 |
| 133 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39500424 |
| 134 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38866878 |
| 135 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38107907 |
| 136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37959236 |
| 137 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.37729525 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.37483452 |
| 139 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.37153697 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.35721046 |
| 141 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.35615528 |
| 142 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.35088091 |
| 143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.34944632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.14409985 |
| 2 | MP0005360_urolithiasis | 7.48028282 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.38148650 |
| 4 | MP0005365_abnormal_bile_salt | 6.09558671 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04445173 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.06006683 |
| 7 | MP0003252_abnormal_bile_duct | 3.95110069 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58875471 |
| 9 | MP0009840_abnormal_foam_cell | 3.35510095 |
| 10 | MP0003122_maternal_imprinting | 3.07448270 |
| 11 | MP0005083_abnormal_biliary_tract | 3.05254486 |
| 12 | MP0005332_abnormal_amino_acid | 2.69987093 |
| 13 | MP0003195_calcinosis | 2.68456678 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.56234412 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.32865634 |
| 16 | MP0000609_abnormal_liver_physiology | 2.17071231 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.13898695 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.07820134 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.92397489 |
| 20 | MP0003868_abnormal_feces_composition | 1.92198791 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.85095797 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.79745187 |
| 23 | MP0001764_abnormal_homeostasis | 1.59716379 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54960470 |
| 25 | MP0009697_abnormal_copulation | 1.50574850 |
| 26 | MP0003011_delayed_dark_adaptation | 1.37097223 |
| 27 | MP0002089_abnormal_postnatal_growth/wei | 1.32289709 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.31419554 |
| 29 | MP0005451_abnormal_body_composition | 1.29650987 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.28682584 |
| 31 | * MP0001915_intracranial_hemorrhage | 1.27144247 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.22292268 |
| 33 | * MP0000598_abnormal_liver_morphology | 1.18351863 |
| 34 | MP0003186_abnormal_redox_activity | 1.16220958 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.14000338 |
| 36 | MP0005647_abnormal_sex_gland | 1.11866096 |
| 37 | MP0000604_amyloidosis | 1.11414989 |
| 38 | MP0009763_increased_sensitivity_to | 1.11058467 |
| 39 | MP0009764_decreased_sensitivity_to | 1.09686096 |
| 40 | MP0002254_reproductive_system_inflammat | 1.08126843 |
| 41 | MP0005164_abnormal_response_to | 1.01491684 |
| 42 | MP0000685_abnormal_immune_system | 0.99979729 |
| 43 | MP0003183_abnormal_peptide_metabolism | 0.99111745 |
| 44 | MP0009785_altered_susceptibility_to | 0.95641743 |
| 45 | MP0003123_paternal_imprinting | 0.94271741 |
| 46 | MP0008469_abnormal_protein_level | 0.93534269 |
| 47 | MP0009642_abnormal_blood_homeostasis | 0.86562509 |
| 48 | MP0005409_darkened_coat_color | 0.86274684 |
| 49 | MP0005670_abnormal_white_adipose | 0.86178783 |
| 50 | MP0008260_abnormal_autophagy | 0.85866320 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 0.84784831 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 0.83894264 |
| 53 | MP0000566_synostosis | 0.82192688 |
| 54 | MP0005408_hypopigmentation | 0.81591061 |
| 55 | MP0002933_joint_inflammation | 0.80402426 |
| 56 | MP0001661_extended_life_span | 0.80142489 |
| 57 | MP0002419_abnormal_innate_immunity | 0.79277867 |
| 58 | MP0003303_peritoneal_inflammation | 0.78708001 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 0.78349234 |
| 60 | MP0003879_abnormal_hair_cell | 0.78210996 |
| 61 | MP0005025_abnormal_response_to | 0.77591492 |
| 62 | MP0009765_abnormal_xenobiotic_induced | 0.76874969 |
| 63 | MP0009053_abnormal_anal_canal | 0.75635856 |
| 64 | MP0002971_abnormal_brown_adipose | 0.75446896 |
| 65 | MP0005376_homeostasis/metabolism_phenot | 0.74050397 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 0.73901681 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 0.73839197 |
| 68 | MP0000858_altered_metastatic_potential | 0.73009157 |
| 69 | MP0002166_altered_tumor_susceptibility | 0.72729027 |
| 70 | MP0003724_increased_susceptibility_to | 0.71767647 |
| 71 | MP0003690_abnormal_glial_cell | 0.71362987 |
| 72 | MP0005334_abnormal_fat_pad | 0.69723908 |
| 73 | MP0006054_spinal_hemorrhage | 0.69406599 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 0.68960315 |
| 75 | MP0001533_abnormal_skeleton_physiology | 0.68571995 |
| 76 | MP0003436_decreased_susceptibility_to | 0.68498163 |
| 77 | MP0002876_abnormal_thyroid_physiology | 0.68494865 |
| 78 | MP0004130_abnormal_muscle_cell | 0.68078623 |
| 79 | MP0000639_abnormal_adrenal_gland | 0.67822173 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 0.66816738 |
| 81 | MP0005535_abnormal_body_temperature | 0.66564165 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.66219370 |
| 83 | MP0000920_abnormal_myelination | 0.66089067 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 0.65545375 |
| 85 | MP0003878_abnormal_ear_physiology | 0.65545375 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.65019899 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.64530928 |
| 88 | MP0005248_abnormal_Harderian_gland | 0.62815467 |
| 89 | MP0003632_abnormal_nervous_system | 0.59900372 |
| 90 | MP0003121_genomic_imprinting | 0.58933391 |
| 91 | MP0001756_abnormal_urination | 0.57568483 |
| 92 | MP0003329_amyloid_beta_deposits | 0.57379881 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.56632096 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.55442534 |
| 95 | MP0005448_abnormal_energy_balance | 0.55250302 |
| 96 | MP0005266_abnormal_metabolism | 0.54896255 |
| 97 | MP0003075_altered_response_to | 0.54812052 |
| 98 | MP0003866_abnormal_defecation | 0.54197684 |
| 99 | MP0005395_other_phenotype | 0.53424799 |
| 100 | MP0002928_abnormal_bile_duct | 0.53093432 |
| 101 | MP0002405_respiratory_system_inflammati | 0.50360353 |
| 102 | MP0001790_abnormal_immune_system | 0.49786590 |
| 103 | MP0005387_immune_system_phenotype | 0.49786590 |
| 104 | MP0001800_abnormal_humoral_immune | 0.49627240 |
| 105 | MP0002168_other_aberrant_phenotype | 0.48235468 |
| 106 | MP0003943_abnormal_hepatobiliary_system | 0.48172562 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.47803487 |
| 108 | MP0001851_eye_inflammation | 0.47654409 |
| 109 | MP0000579_abnormal_nail_morphology | 0.46883475 |
| 110 | MP0008874_decreased_physiological_sensi | 0.44188338 |
| 111 | MP0008873_increased_physiological_sensi | 0.43381478 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.42875326 |
| 113 | MP0005166_decreased_susceptibility_to | 0.42493281 |
| 114 | MP0004381_abnormal_hair_follicle | 0.41512978 |
| 115 | MP0000249_abnormal_blood_vessel | 0.41011196 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.40969255 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.40488774 |
| 118 | MP0001243_abnormal_dermal_layer | 0.39148351 |
| 119 | MP0005187_abnormal_penis_morphology | 0.38805648 |
| 120 | MP0001853_heart_inflammation | 0.38275835 |
| 121 | MP0005666_abnormal_adipose_tissue | 0.37648608 |
| 122 | MP0004883_abnormal_blood_vessel | 0.37594808 |
| 123 | MP0003953_abnormal_hormone_level | 0.35960764 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.35874842 |
| 125 | MP0009672_abnormal_birth_weight | 0.34613266 |
| 126 | MP0000427_abnormal_hair_cycle | 0.34284923 |
| 127 | MP0009115_abnormal_fat_cell | 0.33198693 |
| 128 | MP0002132_abnormal_respiratory_system | 0.33134401 |
| 129 | MP0003718_maternal_effect | 0.32758840 |
| 130 | MP0006082_CNS_inflammation | 0.31968313 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.31808625 |
| 132 | MP0005023_abnormal_wound_healing | 0.31165784 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.30832249 |
| 134 | MP0002970_abnormal_white_adipose | 0.28980723 |
| 135 | MP0004947_skin_inflammation | 0.28818026 |
| 136 | MP0003300_gastrointestinal_ulcer | 0.28775758 |
| 137 | MP0002135_abnormal_kidney_morphology | 0.27964364 |
| 138 | MP0001881_abnormal_mammary_gland | 0.27816638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.35197609 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.29515281 |
| 3 | * Deep venous thrombosis (HP:0002625) | 7.26736986 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.69549213 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.42790760 |
| 6 | * Prolonged partial thromboplastin time (HP:0003645) | 6.40552085 |
| 7 | Xanthomatosis (HP:0000991) | 6.37549508 |
| 8 | Complement deficiency (HP:0004431) | 6.13196106 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.51851226 |
| 10 | Joint hemorrhage (HP:0005261) | 5.04147048 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.83041374 |
| 12 | Abnormality of complement system (HP:0005339) | 4.63203225 |
| 13 | Epidermoid cyst (HP:0200040) | 4.62625536 |
| 14 | Hyperammonemia (HP:0001987) | 4.53097243 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42195205 |
| 16 | * Abnormality of the common coagulation pathway (HP:0010990) | 4.33000059 |
| 17 | Hyperglycinemia (HP:0002154) | 4.29344867 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.28110332 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26124132 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.23425881 |
| 21 | Ketosis (HP:0001946) | 4.15875687 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12012310 |
| 23 | Fat malabsorption (HP:0002630) | 4.11678127 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09295575 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.82807102 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80140559 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78833556 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.78015775 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.77084175 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.74557922 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.74084532 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.74084532 |
| 33 | Hyperglycinuria (HP:0003108) | 3.73341642 |
| 34 | Purpura (HP:0000979) | 3.46191519 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29640696 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.29513717 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.24548887 |
| 38 | Glomerulonephritis (HP:0000099) | 3.22626167 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.21392386 |
| 40 | Myocardial infarction (HP:0001658) | 3.08337564 |
| 41 | Steatorrhea (HP:0002570) | 3.03069634 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02834948 |
| 43 | Spontaneous abortion (HP:0005268) | 3.02736673 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.96849708 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 2.95606159 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.95082841 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.94813416 |
| 48 | Osteomalacia (HP:0002749) | 2.93347406 |
| 49 | Arthropathy (HP:0003040) | 2.89172322 |
| 50 | Ketoacidosis (HP:0001993) | 2.87150733 |
| 51 | Skin nodule (HP:0200036) | 2.85226016 |
| 52 | Vascular calcification (HP:0004934) | 2.64811339 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.64182142 |
| 54 | Acanthocytosis (HP:0001927) | 2.64044130 |
| 55 | Metabolic acidosis (HP:0001942) | 2.60937595 |
| 56 | Mitral stenosis (HP:0001718) | 2.60188967 |
| 57 | Optic neuritis (HP:0100653) | 2.52447469 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.52447469 |
| 59 | Abnormality of carpal bone ossification (HP:0006257) | 2.48994931 |
| 60 | Gingival bleeding (HP:0000225) | 2.45271847 |
| 61 | Abnormal tarsal ossification (HP:0008369) | 2.44526878 |
| 62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44254291 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 2.44254291 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.43611621 |
| 65 | Orchitis (HP:0100796) | 2.42598669 |
| 66 | Lethargy (HP:0001254) | 2.42504726 |
| 67 | Spastic diplegia (HP:0001264) | 2.40809955 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.39963354 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.38199015 |
| 70 | Cholelithiasis (HP:0001081) | 2.33605283 |
| 71 | Amyloidosis (HP:0011034) | 2.31576242 |
| 72 | Irritability (HP:0000737) | 2.31415564 |
| 73 | Cholecystitis (HP:0001082) | 2.30037070 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 2.30037070 |
| 75 | Joint swelling (HP:0001386) | 2.28558598 |
| 76 | Gangrene (HP:0100758) | 2.26348825 |
| 77 | Flat acetabular roof (HP:0003180) | 2.24441712 |
| 78 | Gout (HP:0001997) | 2.23376892 |
| 79 | Neonatal onset (HP:0003623) | 2.21446201 |
| 80 | Nephritis (HP:0000123) | 2.19152294 |
| 81 | Cerebral edema (HP:0002181) | 2.17644088 |
| 82 | Thrombophlebitis (HP:0004418) | 2.16831536 |
| 83 | Asymmetry of the thorax (HP:0001555) | 2.15783148 |
| 84 | * Epistaxis (HP:0000421) | 2.12650390 |
| 85 | Malnutrition (HP:0004395) | 2.12432128 |
| 86 | Small epiphyses (HP:0010585) | 2.11578937 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.08701557 |
| 88 | Broad alveolar ridges (HP:0000187) | 2.08306731 |
| 89 | Myositis (HP:0100614) | 2.06638510 |
| 90 | Pancreatitis (HP:0001733) | 2.05901575 |
| 91 | Hemorrhage of the eye (HP:0011885) | 2.04283215 |
| 92 | Enlarged kidneys (HP:0000105) | 2.02322136 |
| 93 | Late onset (HP:0003584) | 2.01646391 |
| 94 | Poikilocytosis (HP:0004447) | 2.01268893 |
| 95 | Hypochromic anemia (HP:0001931) | 1.97586568 |
| 96 | Opisthotonus (HP:0002179) | 1.95970254 |
| 97 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.94732835 |
| 98 | Brushfield spots (HP:0001088) | 1.94653880 |
| 99 | Abnormality of the gallbladder (HP:0005264) | 1.93675021 |
| 100 | Vomiting (HP:0002013) | 1.93589323 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93121854 |
| 102 | Abnormality of the lumbar spine (HP:0100712) | 1.90314019 |
| 103 | Generalized aminoaciduria (HP:0002909) | 1.89646269 |
| 104 | Potter facies (HP:0002009) | 1.89422447 |
| 105 | Facial shape deformation (HP:0011334) | 1.89422447 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 1.87826698 |
| 107 | Increased serum ferritin (HP:0003281) | 1.87800266 |
| 108 | Rickets (HP:0002748) | 1.86369767 |
| 109 | * Menorrhagia (HP:0000132) | 1.85175624 |
| 110 | Abnormal hand bone ossification (HP:0010660) | 1.84306563 |
| 111 | * Esophageal varix (HP:0002040) | 1.84280625 |
| 112 | Abnormality of the nasal septum (HP:0000419) | 1.83814764 |
| 113 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83742716 |
| 114 | Broad palm (HP:0001169) | 1.83557971 |
| 115 | Arterial thrombosis (HP:0004420) | 1.83389377 |
| 116 | Turricephaly (HP:0000262) | 1.82011505 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 1.81447361 |
| 118 | Abnormal ossification of hand bones (HP:0005921) | 1.80844984 |
| 119 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80465721 |
| 120 | Abnormality of proline metabolism (HP:0010907) | 1.79829077 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.79829077 |
| 122 | Vaginal fistula (HP:0004320) | 1.78449391 |
| 123 | Pulmonary embolism (HP:0002204) | 1.77618022 |
| 124 | Hyperglycemia (HP:0003074) | 1.76327492 |
| 125 | Widely patent fontanelles and sutures (HP:0004492) | 1.74582303 |
| 126 | Hypophosphatemic rickets (HP:0004912) | 1.74080258 |
| 127 | Renal cortical cysts (HP:0000803) | 1.73012702 |
| 128 | Status epilepticus (HP:0002133) | 1.72527970 |
| 129 | Abnormality of vitamin metabolism (HP:0100508) | 1.70551725 |
| 130 | Mucopolysacchariduria (HP:0008155) | 1.69483040 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69483040 |
| 132 | Abnormal foot bone ossification (HP:0010675) | 1.68940408 |
| 133 | Scanning speech (HP:0002168) | 1.66349451 |
| 134 | Abnormality of the Achilles tendon (HP:0005109) | 1.66062292 |
| 135 | Polycythemia (HP:0001901) | 1.64616220 |
| 136 | Keratoconjunctivitis sicca (HP:0001097) | 1.62248264 |
| 137 | Epiphyseal dysplasia (HP:0002656) | 1.61042042 |
| 138 | Flared iliac wings (HP:0002869) | 1.60611838 |
| 139 | Abnormality of the wing of the ilium (HP:0011867) | 1.60336019 |
| 140 | Anorexia (HP:0002039) | 1.59928436 |
| 141 | Elevated alkaline phosphatase (HP:0003155) | 1.58579672 |
| 142 | Abnormal platelet volume (HP:0011876) | 1.57536364 |
| 143 | Episodic fever (HP:0001954) | 1.57274128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.98874170 |
| 2 | ERN1 | 4.46403023 |
| 3 | SIK1 | 4.46055727 |
| 4 | FGFR4 | 4.23108887 |
| 5 | TAOK3 | 3.39551818 |
| 6 | MST1R | 3.18082730 |
| 7 | CDK12 | 2.98806504 |
| 8 | INSRR | 2.94986061 |
| 9 | ERBB4 | 2.55915744 |
| 10 | PKN2 | 2.23238314 |
| 11 | MAP2K4 | 2.16329092 |
| 12 | WNK4 | 2.15708451 |
| 13 | FGFR2 | 2.04815473 |
| 14 | LATS1 | 1.91130234 |
| 15 | WNK1 | 1.83979431 |
| 16 | TYK2 | 1.81327939 |
| 17 | TRIB3 | 1.80328280 |
| 18 | TYRO3 | 1.78943683 |
| 19 | DAPK2 | 1.73874277 |
| 20 | MAPK11 | 1.69067437 |
| 21 | FLT3 | 1.68607122 |
| 22 | PIK3CG | 1.64078190 |
| 23 | CAMK1D | 1.58450963 |
| 24 | PTK6 | 1.56111546 |
| 25 | AKT3 | 1.49822254 |
| 26 | RIPK4 | 1.47667486 |
| 27 | MAP3K2 | 1.46017965 |
| 28 | FGR | 1.43662188 |
| 29 | SIK2 | 1.43524226 |
| 30 | NEK9 | 1.38712005 |
| 31 | FRK | 1.37387182 |
| 32 | MAP3K7 | 1.32545305 |
| 33 | EPHB1 | 1.28430828 |
| 34 | MET | 1.27259986 |
| 35 | JAK2 | 1.26907032 |
| 36 | JAK1 | 1.22947819 |
| 37 | ABL2 | 1.22449798 |
| 38 | RIPK1 | 1.21777726 |
| 39 | PDGFRA | 1.18460997 |
| 40 | MAP2K3 | 1.18295239 |
| 41 | PRKAA2 | 1.13961717 |
| 42 | GRK6 | 1.13751317 |
| 43 | KDR | 1.12483150 |
| 44 | EPHA3 | 1.05179816 |
| 45 | MAP3K10 | 1.04652795 |
| 46 | TBK1 | 1.04405083 |
| 47 | CAMK1G | 1.03170666 |
| 48 | TGFBR2 | 0.96408799 |
| 49 | MAP3K14 | 0.95591086 |
| 50 | MAPK4 | 0.95045009 |
| 51 | ERBB2 | 0.94465569 |
| 52 | KSR2 | 0.94383805 |
| 53 | ITK | 0.90571474 |
| 54 | CSK | 0.90078352 |
| 55 | IRAK4 | 0.84836838 |
| 56 | PRKCZ | 0.82756381 |
| 57 | TNK2 | 0.82732809 |
| 58 | PRPF4B | 0.82555140 |
| 59 | MAPK12 | 0.82516143 |
| 60 | YES1 | 0.81722384 |
| 61 | MAP3K3 | 0.81554654 |
| 62 | MAP3K11 | 0.80639641 |
| 63 | BMX | 0.79685385 |
| 64 | MATK | 0.79542282 |
| 65 | TXK | 0.75838947 |
| 66 | FGFR3 | 0.75709570 |
| 67 | SGK1 | 0.75315302 |
| 68 | CSF1R | 0.74749620 |
| 69 | SGK3 | 0.73278205 |
| 70 | CDK6 | 0.73213016 |
| 71 | CDC42BPA | 0.72629268 |
| 72 | MAPK15 | 0.71582661 |
| 73 | MARK2 | 0.70798407 |
| 74 | BRD4 | 0.68869140 |
| 75 | PINK1 | 0.67456391 |
| 76 | PRKACG | 0.66996499 |
| 77 | GSK3A | 0.65644546 |
| 78 | EIF2AK1 | 0.65487107 |
| 79 | LCK | 0.65380356 |
| 80 | JAK3 | 0.64863957 |
| 81 | TAOK1 | 0.62584228 |
| 82 | SYK | 0.62127703 |
| 83 | MAPK7 | 0.61050159 |
| 84 | PTK2 | 0.59055128 |
| 85 | PRKAA1 | 0.58708179 |
| 86 | IGF1R | 0.58629331 |
| 87 | IRAK3 | 0.57953448 |
| 88 | CAMKK2 | 0.57379563 |
| 89 | FGFR1 | 0.56938711 |
| 90 | IKBKE | 0.56044583 |
| 91 | RPS6KB1 | 0.55623049 |
| 92 | PRKCQ | 0.54342721 |
| 93 | DYRK1B | 0.52444911 |
| 94 | MAP2K6 | 0.51736840 |
| 95 | STK38L | 0.51693516 |
| 96 | MAP3K13 | 0.51012823 |
| 97 | HCK | 0.50394379 |
| 98 | LYN | 0.49230659 |
| 99 | RET | 0.49167296 |
| 100 | FES | 0.49049211 |
| 101 | NTRK3 | 0.48879928 |
| 102 | PDPK1 | 0.48750721 |
| 103 | TIE1 | 0.47975229 |
| 104 | DDR2 | 0.47840160 |
| 105 | CAMK2G | 0.47374644 |
| 106 | PDGFRB | 0.46774523 |
| 107 | SGK2 | 0.46219975 |
| 108 | CDK4 | 0.45649682 |
| 109 | STK38 | 0.45632079 |
| 110 | MAP3K6 | 0.45373411 |
| 111 | BLK | 0.45257887 |
| 112 | CAMK4 | 0.44978106 |
| 113 | MAP4K1 | 0.44800856 |
| 114 | EEF2K | 0.44664253 |
| 115 | EGFR | 0.42415167 |
| 116 | MTOR | 0.40856802 |
| 117 | IRAK1 | 0.39014978 |
| 118 | FYN | 0.38429009 |
| 119 | MAP3K5 | 0.38389804 |
| 120 | MAP3K1 | 0.34764511 |
| 121 | CSNK1G1 | 0.34065877 |
| 122 | PKN1 | 0.33218199 |
| 123 | GRK1 | 0.32080980 |
| 124 | STK3 | 0.31864171 |
| 125 | NLK | 0.30585864 |
| 126 | PDK1 | 0.30170081 |
| 127 | ICK | 0.29976361 |
| 128 | NUAK1 | 0.29858514 |
| 129 | TAOK2 | 0.29657822 |
| 130 | PIK3CA | 0.28596882 |
| 131 | PRKCH | 0.28369597 |
| 132 | ZAP70 | 0.26833759 |
| 133 | CHUK | 0.26354014 |
| 134 | IRAK2 | 0.25380197 |
| 135 | KIT | 0.25154682 |
| 136 | SGK494 | 0.23649296 |
| 137 | SGK223 | 0.23649296 |
| 138 | ABL1 | 0.23626698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53707154 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.83061557 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38195098 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37277692 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07398374 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.00513906 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66716543 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65507094 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53958011 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46530166 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44711335 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31785438 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30454571 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28428178 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09182142 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06516878 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.03544399 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92896094 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90825457 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90547507 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89361158 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87558921 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86038669 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85563838 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76839117 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75427912 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70819235 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70593450 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69863579 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62502016 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54421944 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53452555 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.51242017 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47033341 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41554112 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40294891 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39722330 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32176540 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28798860 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.28405262 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.26191806 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25800642 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22931662 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17052019 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14967702 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13319162 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13106874 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04580770 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95154336 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95069687 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93300445 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89741473 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89690809 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.89004553 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87055741 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86696764 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86129097 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85292112 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80088016 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69662801 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65302877 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64785353 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57620448 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53784771 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52327053 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.46290611 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41446138 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39283964 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34652052 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.27968055 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27938481 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26746548 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24339645 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.19777157 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18373780 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.18137648 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18063011 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17854509 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.13271183 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.12165975 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11977399 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10387948 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09602926 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.08461327 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.06857867 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.05778357 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.05745587 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03203141 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.01804493 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.00932932 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.00462672 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2067214 |
| 93 | Malaria_Homo sapiens_hsa05144 | -0.1970607 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1962173 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1952587 |
| 96 | Lysosome_Homo sapiens_hsa04142 | -0.1925957 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1703049 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1525579 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | -0.1442085 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | -0.1279648 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1261636 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1139196 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1050778 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1020659 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0948227 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0884300 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0876502 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0656084 |
| 109 | Pertussis_Homo sapiens_hsa05133 | -0.0609220 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0560714 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0378579 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | -0.0190683 |
| 113 | Measles_Homo sapiens_hsa05162 | -0.0163213 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0132450 |

